Literature DB >> 19449422

Giant diencephalic harmartoma and related anomalies: a newly recognized entity distinct from the Pallister-Hall syndrome.

Fabien Guimiot1, Pascale Marcorelles, Azzedine Aboura, Georges Bonyhay, Sophie Patrier, Françoise Menez, Valérie Drouin-Garraud, Valentine Icowick, Danièle Eurin, Catherine Garel, Hélène Moirot, Eric Verspyck, Pascale Saugier-Veber, Tania Attie-Bitach, Olivier Picone, Jean François Oury, Alain Verloes, Anne Lise Delezoide, Annie Laquerrière.   

Abstract

An hypothalamic hamartoma is an abnormal mass of mature glio-neuronal tissue present in the hypothalamic area. It usually measures <2 cm of diameter. Most of the time, this hamartoma occurs in Pallister-Hall syndrome (PHS), due to heterozygous GLI3 mutations. We report on five fetuses with giant diencephalic hamartoma and other midline brain and facial malformations, without mutation in the GLI3 gene or genomic rearrangements in three of them. The fetuses showed facial asymmetry, unilateral ear and eye anomalies, and facial cleft. Extracephalic malformations consisted of vertebral anomalies and short nails, without polydactyly and cardiac malformation. The diencephalon was replaced by an encephaloid mass protruding into the facial cleft. Normal cerebral structures were not detectable. In one patient, holoprosencephaly of the syntelencephalic type was noted. Arhinencephaly was present in all patients. Histologically, the ill-defined, multilobulated lesion was made of neuroblastic and neurocytic cell foci, lying in a fibrillar network, elaborating sometimes perivascular pseudorosettes, with a maturation gradient in accordance with the fetal age. Owing to their location, the tumors could be described as diencephalic, rather than hypothalamic hamartomas. The striking asymmetry of the facial anomalies and the diencephalic malformations are not in the spectrum observed with PHS and related syndromes, suggesting a distinct entity involving abnormal morphogenetic developmental fields at around 5 weeks of gestation. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19449422     DOI: 10.1002/ajmg.a.32859

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Description of a giant hypothalamic hamartoma associated with an immature ruptured giant sacrococcygeal teratoma: a case report.

Authors:  Nicolas Serratrice; Alice Faure; Andre Maues de Paula; Nadine Girard; Nicolas André; Didier Scavarda
Journal:  Childs Nerv Syst       Date:  2020-09-25       Impact factor: 1.475

2.  Giant cystic hypothalamic hamartoma in an infant associated with persistent syndrome of inappropriate antidiuretic hormone secretion.

Authors:  Andy Yu-Der Wang; Tai-Tong Wong; Kevin Li-Chun Hsieh; Min-Lan Tsai; Chen Yang
Journal:  Childs Nerv Syst       Date:  2022-01-20       Impact factor: 1.532

3.  Somatic mutations in GLI3 and OFD1 involved in sonic hedgehog signaling cause hypothalamic hamartoma.

Authors:  Hirotomo Saitsu; Masaki Sonoda; Takefumi Higashijima; Hiroshi Shirozu; Hiroshi Masuda; Jun Tohyama; Mitsuhiro Kato; Mitsuko Nakashima; Yoshinori Tsurusaki; Takeshi Mizuguchi; Satoko Miyatake; Noriko Miyake; Shigeki Kameyama; Naomichi Matsumoto
Journal:  Ann Clin Transl Neurol       Date:  2016-03-24       Impact factor: 4.511

4.  Semi Lobar Holoprosencephaly with Vertebral Segmentation Defects.

Authors:  Birendra Rai; Farhana Sharif
Journal:  Iran J Child Neurol       Date:  2017
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.